reports
Ring Energy Updates Second Quarter 2025 Guidance
Ring Energy Updates Second Quarter 2025 Guidance ~ Reaffirms Sales Volume Guidance and Substantially Reduces Capital Guidance ~ THE WOODLANDS, Texas, April 24, 2025 (GLOBE NEWSWIRE) -- Ring Energy, Inc. (NYSE American: REI) (“Ring” or the “Company”) today provided updated guidance for the second quarter of 2025, which included reaffirming its previous outlook for oil and total sales volumes despite a significant reduction in the Company’s capital spending guidance, which was lowered in response to the recent decline in oil prices. KEY Q2 UPDATED GUIDANCE HIGHLIGHTS Reduce...
Ring Energy Provides Operational Update - Amended to Correct Wells Dri...
Ring Energy Provides Operational Update - Amended to Correct Wells Drilled in First Quarter 2025 ~ Announces Timing of First Quarter Earnings Conference Call ~ THE WOODLANDS, Texas, April 18, 2025 (GLOBE NEWSWIRE) -- Ring Energy, Inc. (NYSE American: REI) (“Ring” or the “Company”) today provided an operational update, including first quarter 2025 oil sales volumes above the high end of the Company’s guidance range and total sales volumes above the midpoint of guidance. The Company also announced the timing of Ring’s quarterly results conference call. KEY HIGHLIGHTS Produced over 12,000...
Ring Energy Provides Operational Update
Ring Energy Provides Operational Update ~ Announces Timing of First Quarter Earnings Conference Call ~ THE WOODLANDS, Texas, April 17, 2025 (GLOBE NEWSWIRE) -- Ring Energy, Inc. (NYSE American: REI) (“Ring” or the “Company”) today provided an operational update, including first quarter 2025 oil sales volumes above the high end of the Company’s guidance range and total sales volumes above the midpoint of guidance. The Company also announced the timing of Ring’s quarterly results conference call. KEY HIGHLIGHTS Produced over 12,000 barrels of oil per day (“Bo/d”), exceeding h...
Ring Energy Provides Board of Directors Update
Ring Energy Provides Board of Directors Update THE WOODLANDS, Texas, April 11, 2025 (GLOBE NEWSWIRE) -- Ring Energy, Inc. (NYSE American: REI) (“Ring” or the “Company”) today provided an update concerning its Board of Directors (the “Board”), including the retirement of Ms. Regina Roesener effective April 14, 2025 and the appointment of Ms. Carla Tharp to the Board effective April 14, 2025 who will serve as an independent Director. Mr. Paul D. McKinney, Chairman of the Board and Chief Executive Officer, commented, “It has been a pleasure to work closely with Regina as a fellow Director...
Clearside Biomedical to Participate in a Fireside Chat at the 24th Ann...
Clearside Biomedical to Participate in a Fireside Chat at the 24th Annual Needham Virtual Healthcare Conference ALPHARETTA, Ga., April 01, 2025 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (Nasdaq: CLSD), a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space (SCS®), announced today that George Lasezkay, PharmD, JD, President and Chief Executive Officer, and Victor Chong, M.D., MBA, Chief Medical Officer and EVP, Head of Research & Development, will participate in a fireside chat at the 24th Annual Needham Virtual He...
Ring Energy Announces the Closing of the Lime Rock Permian Basin Asset...
Ring Energy Announces the Closing of the Lime Rock Permian Basin Assets Acquisition THE WOODLANDS, Texas, April 01, 2025 (GLOBE NEWSWIRE) -- Ring Energy, Inc. (NYSE American: REI) (“Ring” or the “Company”) announced that it has completed its previously-announced acquisition (the “Transaction”) of the Central Basin Platform (“CBP”) assets of Lime Rock Resources IV, LP (“Lime Rock”) on March 31, 2025. Lime Rock’s CBP operations are located in the Permian Basin in Andrews County, Texas, and are focused on the development of approximately 17,700 net acres where the majority are similar to Rin...
Ring Energy to Participate in Water Tower Research Fireside Chat on Ap...
Ring Energy to Participate in Water Tower Research Fireside Chat on April 1, 2025 THE WOODLANDS, Texas, March 27, 2025 (GLOBE NEWSWIRE) -- Ring Energy, Inc. (NYSE American: REI) (“Ring” or the “Company”) today announced its participation in a fireside chat with Water Tower Research (“WTR”) on Tuesday, April 1, 2025 at 10:00 AM Central Time. As part of WTR’s ongoing Fireside Chat Series, Jeff Robertson, Managing Director at WTR, will lead an in-depth conversation with Paul McKinney, Ring’s Chairman and Chief Executive Officer. Included in the discussion will be a variety of important topi...
Clearside Biomedical Announces Fourth Quarter and Full Year 2024 Finan...
Clearside Biomedical Announces Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update - Successful End-of-Phase 2 Meeting with FDA Results in Alignment on Phase 3 Plans for CLS-AX in Wet AMD - - Asia-Pacific Partner’s New Drug Application for ARCATUS® (XIPERE®) for Uveitic Macular Edema Accepted for Regulatory Review in China - - Multiple Medical Meeting Presentations Highlight Potential Advantages and Key Differentiators of Suprachoroidal Drug Delivery Utilizing Clearside’s SCS Microinjector® - - Management to Host Webcast and Conference Call Today at 4:...
Clearside Biomedical Announces Six Abstracts Accepted for Presentation...
Clearside Biomedical Announces Six Abstracts Accepted for Presentation at Association for Research in Vision and Ophthalmology (ARVO) 2025 Meeting - Suprachoroidal Delivery Develops as Promising Mainstream Procedure for Treating Multiple Macular Diseases - - SCS Microinjector® Provides Targeted and Compartmentalized Delivery of Therapeutics Directly to the Retina - ALPHARETTA, Ga., March 24, 2025 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (Nasdaq: CLSD) (“Clearside” or the “Company”), a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye th...
Clearside Biomedical’s Lead Clinical Program CLS-AX in Wet AMD and Su...
Clearside Biomedical’s Lead Clinical Program CLS-AX in Wet AMD and Suprachoroidal Delivery Platform Highlighted at the 2025 Wet AMD & Diabetic Eye Disease Summit - Post-Hoc Analyses Provide Comparative Data on Rescue Criteria and Intervention-Free Rates for Tyrosine Kinase Inhibitors (TKIs) in Wet AMD Development - - Unique Ability to Re-Dose CLS-AX vs Rescue Supports Regulatory & Commercial Strategy - ALPHARETTA, Ga., March 20, 2025 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (Nasdaq: CLSD) (“Clearside” or the “Company”), a biopharmaceutical company revolutionizing the delivery o...
Clearside Biomedical to Report Fourth Quarter and Full Year 2024 Finan...
Clearside Biomedical to Report Fourth Quarter and Full Year 2024 Financial Results and Provide Corporate Update on Thursday, March 27, 2025 ALPHARETTA, Ga., March 12, 2025 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (Nasdaq: CLSD) (“Clearside” or the “Company”), a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space (SCS®), announced today that its fourth quarter and full year 2024 financial results will be reported on Thursday, March 27, 2025 after the close of the financial markets. Management will host a webcast ...
Clearside Biomedical Announces Successful End-of-Phase 2 Meeting with ...
Clearside Biomedical Announces Successful End-of-Phase 2 Meeting with the FDA and Alignment on Phase 3 Plans for Suprachoroidal CLS-AX in Wet AMD - CLS-AX Phase 3 Program Designed to Maximize Commercial Potential in Wet AMD - - Flexible Dosing and Extended Duration would be Important Differentiators from Existing Approved Therapies and Other Tyrosine Kinase Inhibitors in Development - ALPHARETTA, Ga., March 06, 2025 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (Nasdaq: CLSD) (“Clearside” or the “Company”), a biopharmaceutical company revolutionizing the delivery of therapies to th...
Ring Energy Announces Fourth Quarter and Full Year 2024 Results, Year-...
Ring Energy Announces Fourth Quarter and Full Year 2024 Results, Year-End 2024 Proved Reserves, and 2025 Guidance THE WOODLANDS, Texas, March 05, 2025 (GLOBE NEWSWIRE) -- Ring Energy, Inc. (NYSE American: REI) (“Ring” or the “Company”) today reported operational and financial results for the fourth quarter and full year 2024, year-end 2024 proved reserves and provided 2025 operational and financial guidance. Fourth Quarter 2024 Highlights Recorded net income of $5.7 million, or $0.03 per diluted share;Report...
Ring Energy Announces Accretive Bolt-On Acquisition
Ring Energy Announces Accretive Bolt-On Acquisition ~ Capturing Synergies and Expanding Central Basin Platform Operations ~ ~ Announces Timing of Q4 and FY 2024 Earnings Release and Conference Call ~ THE WOODLANDS, Texas, Feb. 26, 2025 (GLOBE NEWSWIRE) -- Ring Energy, Inc. (NYSE American: REI) (“Ring” or the “Company”) today announced it has entered into an agreement to acquire the Central Basin Platform (“CBP”) assets of Lime Rock Resources IV, LP (“Lime Rock”) for $100 million, subject to customary closing adjustments. The purchase price is comprised of $80 millio...
- Jonathan Moreland
WYNN WYNN RESORTS LIMITED
TTSH TILE SHOP HOLDINGS INC.
OXBR OXBRIDGE RE HOLDINGS
NGL NGL ENERGY PARTNERS LP
HMC HARMONIC
HII HUNTINGTON INGALLS INDUSTRIES INC.
EL ESTEE LAUDER COMPANIES INC. CLASS A
CVS CVS HEALTH CORPORATION
CPSI COMPUTER PROGRAMS & SYSTEMS INC.
BZH BEAZER HOMES USA INC.
BMY BRISTOL-MYERS SQUIBB COMPANY
ASYS AMTECH SYSTEMS INC.
ARCC ARES CAPITAL CORPORATION
AIG AMERICAN INTERNATIONAL GROUP INC.
MDU MDU RESOURCES GROUP INC
CMCO COLUMBUS MCKINNON CORPORATION
USFD US FOODS HOLDING CORP.
FRD FRIEDMAN INDUSTRIES INC.
PLBC PLUMAS BANCORP
FBK FB FINANCIAL CORPORATION
MRUS MERUS B V
PFE PFIZER INC.
XFLT XAI OCTAGON FLOATING RATE ALTERNATIVE INCOME TERM TRUST
RCUS ARCUS BIOSCIENCES
NWPP NEW PEOPLES BANKSHARES INC.
EAF GRAFTECH INTERNATIONAL
AMCR AMCOR PLC
BFC BANK FIRST NATIONAL CORP
CBKM CONSUMERS BANCORP INC.
IDYA IDEAYA BIOSCIENCES
RZLT REZOLUTE
REYN INC.
MTCH REYNOLDS CONSUMER PRODUCTS INC.
ESOA MATCH GROUP INC.
ATAI ENERGY SERVICES OF AMERICA CORP.
FLNC ATAI LIFE SCIENCES BV
BST FLUENCE ENERGY INC
PCT BLACKROCK SCIENCE AND TECHNOLOGY TRUST
CMPO PURECYCLE TECHNOLOGIES INC
EFSI COMPOSECURE INC
LSMG EAGLE FINANCIAL SERVICES INC
SLDB LODE STAR MINING INC
RCEL SOLID BIOSCIENCES INC
MNR AVITA MEDICAL INC
OCX MACH NATURAL RESOURCES LP
FDBC ONCOCYTE CORPORATION
FIDELITY D & D BANCORP INC
Clearside Biomedical’s Asia-Pacific Partner, Arctic Vision, Announced ...
Clearside Biomedical’s Asia-Pacific Partner, Arctic Vision, Announced Acceptance of its New Drug Application for ARCATUS® for Regulatory Review in China for the Treatment of Uveitic Macular Edema ALPHARETTA, Ga., Feb. 20, 2025 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (Nasdaq: CLSD) (“Clearside” or the “Company”), a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space (SCS®), reported that Arctic Vision’s New Drug Application (NDA) for ARCATUS® for the treatment of uveitic macular edema (UME) has been formally acc...
- Jonathan Moreland
TTSH TILE SHOP HOLDINGS INC.
PBF PBF ENERGY INC. CLASS A
NGL NGL ENERGY PARTNERS LP
HBI HANESBRANDS INC.
CPSI COMPUTER PROGRAMS & SYSTEMS INC.
ASYS AMTECH SYSTEMS INC.
AIG AMERICAN INTERNATIONAL GROUP INC.
CMCO COLUMBUS MCKINNON CORPORATION
DYN DYNEGY INC.
FLWS 1-800-FLOWERS.COM CL A
MRUS MERUS B V
NWPP NEW PEOPLES BANKSHARES INC.
ESOA ENERGY SERVICES OF AMERICA CORP.
FLNC FLUENCE ENERGY INC
AEI ALSET INC.
Clearside Biomedical Announces Additional Data from the CLS-AX ODYSSEY...
Clearside Biomedical Announces Additional Data from the CLS-AX ODYSSEY Phase 2b Trial Presented at the Angiogenesis, Exudation, and Degeneration 2025 Meeting - BCVA and CST Data from Sub-Group Analyses Provide Key Insights for Planned CLS-AX Phase 3 Trial Design - ALPHARETTA, Ga., Feb. 10, 2025 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (Nasdaq: CLSD) (“Clearside” or the “Company”), a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space (SCS®), announced today that two subgroup analyses were presented from the O...
Clearside Biomedical to Participate in Fireside Chat at the Oppenheime...
Clearside Biomedical to Participate in Fireside Chat at the Oppenheimer 35th Annual Healthcare Life Sciences Virtual Conference ALPHARETTA, Ga., Feb. 04, 2025 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (Nasdaq: CLSD), a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space (SCS®), announced today George Lasezkay, PharmD, JD, President and Chief Executive Officer, and Victor Chong, MD, MBA, Chief Medical Officer and EVP, Head of Research and Development, will participate in a Fireside Chat at the Oppenheimer 35th Ann...
Clearside Biomedical Announces Multiple Medical Meeting Presentations ...
Clearside Biomedical Announces Multiple Medical Meeting Presentations Focused on the Advantages of Suprachoroidal Delivery and Key Differentiators in its CLS-AX Clinical Program - Upcoming Presentations at Angiogenesis and Macula Society Conferences to Feature CLS-AX Sub-Group Analyses from ODYSSEY Wet AMD Trial - - CLS-AX Targets Flexible Dosing of Biologics with Duration of Tyrosine Kinase Inhibitors - ALPHARETTA, Ga., Jan. 28, 2025 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (Nasdaq: CLSD), a biopharmaceutical company revolutionizing the delivery of therapies to the back of the e...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.